GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults Article Swipe
Related Concepts
Gorilla
Coronavirus disease 2019 (COVID-19)
Virology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2019-20 coronavirus outbreak
Medicine
Immunology
Biology
Outbreak
Disease
Infectious disease (medical specialty)
Internal medicine
Paleontology
Simone Lanini
,
Stefania Capone
,
Andrea Antinori
,
Stefano Milleri
,
Emanuele Nicastri
,
Roberto Camerini
,
Chiara Agrati
,
Concetta Castilletti
,
Federica Mori
,
Alessandra Sacchi
,
Giulia Matusali
,
Roberta Gagliardini
,
Virginia Ammendola
,
Eleonora Cimini
,
Fabiana Grazioli
,
Laura Scorzolini
,
Federico Napolitano
,
Maria Maddalena Plazzi
,
Marco Soriani
,
Aldo De Luca
,
Simone Battella
,
Andrea Sommella
,
Alessandra M. Contino
,
Federica Barra
,
Michela Gentile
,
Angelo Raggioli
,
Yufang Shi
,
Enrico Girardi
,
Markus Maeurer
,
Maria Rosaria Capobianchi
,
Francesco Vaia
,
Mauro Piacentini
,
Guido Kroemer
,
Alessandra Vitelli
,
Stefano Colloca
,
Antonella Folgori
,
Giuseppe Ippolito
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1126/scitranslmed.abj1996
· OA: W3208335625
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1126/scitranslmed.abj1996
· OA: W3208335625
Related Topics
Finding more related topics…